ATG-105

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameATG-105
Drug Alias NameATG-105ATG105
ClassificationBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsDelta-like protein 3 modulators
TargetsT cell surface glycoprotein CD3Delta-like protein 3
Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corp Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A